Clonal evolution of hematopoietic stem cells after cancer chemotherapy
Hidetaka Uryu(The University of Texas MD Anderson Cancer Center), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Ken Furudate(The University of Texas MD Anderson Cancer Center), Michael Spencer Chapman(Wellcome Sanger Institute), Courtney D. DiNardo(The University of Texas MD Anderson Cancer Center), Muzaffar H. Qazilbash(The University of Texas MD Anderson Cancer Center), Shujuan Chen(The University of Texas MD Anderson Cancer Center), Nitin Jain(Parul University), Xingzhi Song(The University of Texas MD Anderson Cancer Center), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Erika J. Thompson(The University of Texas MD Anderson Cancer Center), Simona Colla(The University of Texas MD Anderson Cancer Center), Hongli Tang(The University of Texas MD Anderson Cancer Center), Daisuke Nakada(Baylor College of Medicine), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Rashmi Kanagal‐Shamanna(The University of Texas MD Anderson Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), P. Andrew Futreal(Wellcome Sanger Institute), Joanne I. Hsu(Brigham and Women's Hospital), Naval Daver(The University of Texas MD Anderson Cancer Center), Margaret A. Goodell(Baylor College of Medicine), Chiraag D. Kapadia(Baylor College of Medicine), Kapil N. Bhalla(The University of Texas MD Anderson Cancer Center), Zongrui Li(The University of Texas MD Anderson Cancer Center), Hiroshi Haeno(Tokyo University of Science), Jyoti Nangalia(Wellcome Sanger Institute), Naveen Pemmaraju(The University of Texas MD Anderson Cancer Center), Curtis Gumbs(The University of Texas MD Anderson Cancer Center), Latasha Little(The University of Texas MD Anderson Cancer Center), Jianhua Zhang(XinHua Hospital), Hui Yang(Wannan Medical College), Chong Zhao(The University of Texas MD Anderson Cancer Center), Li Zhao(The University of Texas MD Anderson Cancer Center), Koichi Saeki(Tokyo University of Science), Carlos Bueso- Ramos(The University of Texas MD Anderson Cancer Center), Farhad Ravandi(The University of Texas MD Anderson Cancer Center), Hagop Kantarjian(The University of Texas MD Anderson Cancer Center), Tomoyuki Tanaka(Jikei University School of Medicine)
Cited by 6
Related Papers
The cancer genome
|Nature|2009|3.5k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k